Your browser doesn't support javascript.
loading
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD.
Toto, Robert; Petersen, Jeffrey; Berns, Jeffrey S; Lewis, Eldrin Foster; Tran, Qui; Weir, Matthew R.
Affiliation
  • Toto R; University of Texas Southwestern Medical Center, Dallas, Texas.
  • Petersen J; Amgen Inc., Thousand Oaks, California.
  • Berns JS; Perelman School of Medicine at the University of Pennsylvania and Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lewis EF; Stanford University Medical School, Stanford, California.
  • Tran Q; Amgen Inc., Thousand Oaks, California.
  • Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
J Am Soc Nephrol ; 32(2): 469-478, 2021 02.
Article in En | MEDLINE | ID: mdl-33288629

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythrocyte Transfusion / Renal Insufficiency, Chronic / Darbepoetin alfa / Hematinics / Anemia Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythrocyte Transfusion / Renal Insufficiency, Chronic / Darbepoetin alfa / Hematinics / Anemia Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2021 Document type: Article Country of publication: United States